Preparation method of ferroferric oxide surface double-modified adriamycin targeted drug
A technology of ferric tetroxide and doxorubicin is applied in the field of preparation of doxorubicin-targeted drugs, which can solve problems such as insufficient sensitivity, and achieve the effects of overcoming drug resistance, rational reaction design, and reducing toxic and side effects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0011] Measure 5~10mL of ammonia water and 2~5mL of hydrazine hydrate, and dissolve 50~70mL of deionized water in a three-neck bottle, raise the temperature to 80~100°C, and weigh 1~2g of FeCl 2 4H 2 O and 2~3g FeCl 3 ·6H 2 O, dissolved in 20~30mL water, added to a three-necked bottle to form a reaction solution system to react until the solution system turns black, stir vigorously at 80~95°C for 30~60min, and then stir when the pH of the solution is 9~10 Add 10~20mL of citric acid with a concentration of 0.3g / mL dropwise, and continue to stir for 1.5~2 h after the dropwise addition. After cooling to room temperature, use an external strong magnet to collect the black product, and wash the obtained product with a mixture of deionized water and acetone several times to remove the unreacted citric acid, and vacuum-dry the black product at 30-50°C for 12-24 hours to obtain citric acid-modified ferric oxide (Fe 3 o 4 )Nanoparticles. Take 5~10g of citric acid-modified ferrofer...
Embodiment 2
[0013] Precisely weigh Fe with maximum drug loading rate 3 o 4 The surface double-modified doxorubicin targeted drug was properly dispersed in PBS buffer solution with pH=7.4, the solution volume was 2-4 mL, placed in a dialysis bag, and put into a brown vial containing 8-10 mL, 37 10 min, 30 min, 1 h, 2 h, 4 h, 8 h, 12 h, 24 h, 48 h, and 72 h were sampled 1-2 mL for in vitro release investigation, and the same volume of fresh Release the medium, take the supernatant to measure the UV absorbance value, and calculate the cumulative drug release rate. The result is that the release rate of doxorubicin under the condition of pH=5 is higher than that under the condition of pH=7.4, which are 78% and 27%, respectively, and has obvious pH sensitivity and good slow-release performance.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com